Внезапная сердечная смерть. Меняют ли результаты рандомизированных исследований наши представления о возможных предикторах и путях профилактики?
Download
2. Bigger Th., Whang W., Rottman J. et al. Mechanisms of death in the CABG Patch Trial. A randomized Trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after bypass graft surgery // Circulation. – 1999. – Vol. 99. – P. 1416–1421.
3. Bloomfield D. M., Hohnloser S. H., Cohen R. J. Interpretation and classification of microvolt T-wave alternans tests // J. Cardiovasc. Electrophysiol. – 2002. – Vol. 13. – P. 505–512.
4. Boersmsa L. V. T-wave alternans: predicting the unpredictible // Eur. Heart J. – 2007. – Vol. 28. – P. 2303–2304.
5. Camm J., Klein H., Nisam S. The cost of implantable defibrillators: perceptions and reality // Ibid. – 2007. – Vol. 28. – P. 392–398.
6. Davies M. J., Thomas A. Plaque fissuring – the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina // Brit. Heart J. – 1985. – Vol. 53. – P. 363–373.
7. Ellery S., Williams L., Frenneaux M. Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure // Postgrad. Med. J. – 2006. – Vol. 82. – P. 16–23.
8. Farb A., Tang A., Burke A. P. et al. Sudden coronary death frequency of active coronary lessions, inactive coronary lesions and myocardial infarction // Circulation. – 1995. – Vol. 92. – P. 1701–1709.
9. Gehi A. K., Stein R. H., Metz L. D., Gomes A. J. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: A meta-analysis // J. Amer. Coll. Cardiol.– 2005.– Vol. 46. – P. 75–82.
10. Grimm W., Christ M., Bach J. et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the marburg cardiomyopathy study // Circulation. – 2003.– Vol. 108. – P. 2883–2891.
11. Hallstrom A. P., Ornato J. P., Weisfeldt M. Publicaccess defibrillation and survival after out-of-hospital cardiac arrest. The public access defibrillation trial investigators // N. Engl. J. Med. – 2004. – Vol. 351. – P. 637–646.
12. Hazinski M., Idris A., Kerber R. et al. Lay rescue automated external defibrillator («PAD») Programs. Lessions learned from an international multicenter trial. Advisory Statement From the American Heart Association Emergency Cardiovascular Committee; the Council on Cardiopulmonary, Perioperative, and Critical Care; and the Council on Clinical Cardiology // Circulation. – 2005. – Vol. 111. – P. 3336–3340.
13. Heidbuchel H. The cost of implantable defibrillators: how the perception of reality depends on perspective // Eur. Heart J. – 2007. – Vol. 28. – P. 386–388.
14. Hlatky M. A., Mark D. B. The high cost of implantable defibrillators // Ibid. – 2007. – Vol. 28. – P. 388–392.
15. Hohnloser S. H., Ikeda T., Bloomfield D. M. et al. T-wave alternans negative in coronary patients with low ejection fraction and benefit from defibrillator implantation // Lanset. – 2003. – Vol. 362. – P. 125–126.
16. Huikuri H., Castellanos A., Myerburg R. J. Sudden death due to cardiac arrhythmias // N. Engl. J. Med. – 2001. – Vol. 345. – P. 341–348.
17. Kwong R. Y., Chan A. K., Brown K. A. et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease // Circulation. – 2006. – Vol. 113. – P. 2733–2743.
18. Lane R. E., Martin R. C., Chow A. W. Prediction and prevention of sudden cardiac death in heart failure // Heart. – 2005. – Vol. 91. – P. 674–680.
19. Lawrence J., Gyorkos T. W., Coupa L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard // Amer. J. Epidemiol. – 1995. – Vol. 141. – P. 263–272.
20. Leber A. W., Johnson Th., Becker A. et al. Diagnostic accuracy of dual- source multi- slice CT- angiography in pts with intermediate pretest likelihood for coronary artery disease // Eur. Heart J. – 2007. – Vol. 28. – P. 2354–2360.
21. Myerburg R. J., Estes N. A., Fontaine J. M. et al. Task Force 10: Automated external defibrillators // J. Amer. Coll. Cardiol. – 2005. – Vol. 45. – P. 1369–1371.
22. Nieminen T., Lertimaki T, Viik J. et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test // Eur. Heart J. – 2007. – Vol. 28. – P. 2332–2337.
23. Proclemer A., Chidina M. Application of the main implantable cardioverter defibrillator trials and the 2006 Guidelines for management of patients with ventricular arhythmias and prevention of sudden cardiac death // J. Cardiovasc. Med. – 2007. – Vol. 8. – P. 320–324.
24. Riegel B., Birnbaum A., Aufderheide T. P. et al. PAD investigators predictors of cardiopulmonary resuscitation and automated external defibrillator skill retention // Amer. Heart J. – 2005. – Vol. 150, № 5. – P. 927–932.
25. Sanders G. D., Al-Khatib S. M., Berliner E. Preventing tomorrow’s sudden cardiac death today: Part II: Translating sudden cardiac death risk assessment strategies into practice and policy // Ibid. – 2007. – Vol. 153. – P. 951–959.
26. Santini M., Lawalle C., Ricci R. P. Primary and secondary prevention of sudden cardiac death: who should get an ICD? // Heart. – 2007. – Vol. 93. – P. 1478–1483.
27. Shah J. S., Maisel W. H. Recalls and safety alerts affecting automated external defibrillators // JAMA. – 2006. – Vol. 296. – P. 655–660.
28. Solomon S. D., Zelenkofske S., McMurray L. V. et al. for the VALIANT investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both // N. Engl. J. Med. – 2005. – Vol. 352. – P. 2581–2588.
29. Tapanainen J. M., Lindgren K. S., Maђkikallio T. H. et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era // JACC. – 2004. – Vol. 43. – P. 757–763.
30. Virmani R., Kolodgie F. D., Burke A. P. et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions arterioscler // Thromb. Vasc. Biol. – 2000. – Vol. 20. – P. 1262–1275.
31. Zipes D. P., Camm J. A. et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive Summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration With the European Heart Rhythm Association and the Heart Rhythm Society // Circulation. – 2006. – Vol. 114. – P. 1088–1132.
References
1. Al-Khatib S. M., Sanders G. D., Bigger J. T. et al. Preventing tomorrow’s sudden cardiac death today: Part I: Current data on risk stratification for sudden cardiac death // Amer. Heart J. – 2007. – Vol. 153. – P. 941–950.2. Bigger Th., Whang W., Rottman J. et al. Mechanisms of death in the CABG Patch Trial. A randomized Trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after bypass graft surgery // Circulation. – 1999. – Vol. 99. – P. 1416–1421.
3. Bloomfield D. M., Hohnloser S. H., Cohen R. J. Interpretation and classification of microvolt T-wave alternans tests // J. Cardiovasc. Electrophysiol. – 2002. – Vol. 13. – P. 505–512.
4. Boersmsa L. V. T-wave alternans: predicting the unpredictible // Eur. Heart J. – 2007. – Vol. 28. – P. 2303–2304.
5. Camm J., Klein H., Nisam S. The cost of implantable defibrillators: perceptions and reality // Ibid. – 2007. – Vol. 28. – P. 392–398.
6. Davies M. J., Thomas A. Plaque fissuring – the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina // Brit. Heart J. – 1985. – Vol. 53. – P. 363–373.
7. Ellery S., Williams L., Frenneaux M. Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure // Postgrad. Med. J. – 2006. – Vol. 82. – P. 16–23.
8. Farb A., Tang A., Burke A. P. et al. Sudden coronary death frequency of active coronary lessions, inactive coronary lesions and myocardial infarction // Circulation. – 1995. – Vol. 92. – P. 1701–1709.
9. Gehi A. K., Stein R. H., Metz L. D., Gomes A. J. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: A meta-analysis // J. Amer. Coll. Cardiol.– 2005.– Vol. 46. – P. 75–82.
10. Grimm W., Christ M., Bach J. et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the marburg cardiomyopathy study // Circulation. – 2003.– Vol. 108. – P. 2883–2891.
11. Hallstrom A. P., Ornato J. P., Weisfeldt M. Publicaccess defibrillation and survival after out-of-hospital cardiac arrest. The public access defibrillation trial investigators // N. Engl. J. Med. – 2004. – Vol. 351. – P. 637–646.
12. Hazinski M., Idris A., Kerber R. et al. Lay rescue automated external defibrillator («PAD») Programs. Lessions learned from an international multicenter trial. Advisory Statement From the American Heart Association Emergency Cardiovascular Committee; the Council on Cardiopulmonary, Perioperative, and Critical Care; and the Council on Clinical Cardiology // Circulation. – 2005. – Vol. 111. – P. 3336–3340.
13. Heidbuchel H. The cost of implantable defibrillators: how the perception of reality depends on perspective // Eur. Heart J. – 2007. – Vol. 28. – P. 386–388.
14. Hlatky M. A., Mark D. B. The high cost of implantable defibrillators // Ibid. – 2007. – Vol. 28. – P. 388–392.
15. Hohnloser S. H., Ikeda T., Bloomfield D. M. et al. T-wave alternans negative in coronary patients with low ejection fraction and benefit from defibrillator implantation // Lanset. – 2003. – Vol. 362. – P. 125–126.
16. Huikuri H., Castellanos A., Myerburg R. J. Sudden death due to cardiac arrhythmias // N. Engl. J. Med. – 2001. – Vol. 345. – P. 341–348.
17. Kwong R. Y., Chan A. K., Brown K. A. et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease // Circulation. – 2006. – Vol. 113. – P. 2733–2743.
18. Lane R. E., Martin R. C., Chow A. W. Prediction and prevention of sudden cardiac death in heart failure // Heart. – 2005. – Vol. 91. – P. 674–680.
19. Lawrence J., Gyorkos T. W., Coupa L. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard // Amer. J. Epidemiol. – 1995. – Vol. 141. – P. 263–272.
20. Leber A. W., Johnson Th., Becker A. et al. Diagnostic accuracy of dual- source multi- slice CT- angiography in pts with intermediate pretest likelihood for coronary artery disease // Eur. Heart J. – 2007. – Vol. 28. – P. 2354–2360.
21. Myerburg R. J., Estes N. A., Fontaine J. M. et al. Task Force 10: Automated external defibrillators // J. Amer. Coll. Cardiol. – 2005. – Vol. 45. – P. 1369–1371.
22. Nieminen T., Lertimaki T, Viik J. et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test // Eur. Heart J. – 2007. – Vol. 28. – P. 2332–2337.
23. Proclemer A., Chidina M. Application of the main implantable cardioverter defibrillator trials and the 2006 Guidelines for management of patients with ventricular arhythmias and prevention of sudden cardiac death // J. Cardiovasc. Med. – 2007. – Vol. 8. – P. 320–324.
24. Riegel B., Birnbaum A., Aufderheide T. P. et al. PAD investigators predictors of cardiopulmonary resuscitation and automated external defibrillator skill retention // Amer. Heart J. – 2005. – Vol. 150, № 5. – P. 927–932.
25. Sanders G. D., Al-Khatib S. M., Berliner E. Preventing tomorrow’s sudden cardiac death today: Part II: Translating sudden cardiac death risk assessment strategies into practice and policy // Ibid. – 2007. – Vol. 153. – P. 951–959.
26. Santini M., Lawalle C., Ricci R. P. Primary and secondary prevention of sudden cardiac death: who should get an ICD? // Heart. – 2007. – Vol. 93. – P. 1478–1483.
27. Shah J. S., Maisel W. H. Recalls and safety alerts affecting automated external defibrillators // JAMA. – 2006. – Vol. 296. – P. 655–660.
28. Solomon S. D., Zelenkofske S., McMurray L. V. et al. for the VALIANT investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both // N. Engl. J. Med. – 2005. – Vol. 352. – P. 2581–2588.
29. Tapanainen J. M., Lindgren K. S., Maђkikallio T. H. et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era // JACC. – 2004. – Vol. 43. – P. 757–763.
30. Virmani R., Kolodgie F. D., Burke A. P. et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions arterioscler // Thromb. Vasc. Biol. – 2000. – Vol. 20. – P. 1262–1275.
31. Zipes D. P., Camm J. A. et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive Summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration With the European Heart Rhythm Association and the Heart Rhythm Society // Circulation. – 2006. – Vol. 114. – P. 1088–1132.
